Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLungCancerTeam Member asked a question 💭
Germany
November 25, 2024
 · 
Reactions
A MyLungCancerTeam Member

Yes it does Mark77. It's one of the rarer mutations and they are still trying to find things that disrupt it's growth. Kras g12c doesn't have a lot of options but at least there are a few.

November 25, 2024
A MyLungCancerTeam Member

That is what my onchologist said. Stinks 🥺

November 25, 2024
A MyLungCancerTeam Member

Did a no name trial at Dana Farber Cancer Institute in Boston and way too many side effects and dropped out as cat scan showed the cancer getting stronger doing the trial. On chemo, but only have had one treatment. Next one Dec. 2nd. That trial was working for some g12c and they were trying it on g13c.

November 25, 2024
A MyLungCancerTeam Member

Hi Nathalie, I also can not do immunotherapy as like you do not have PD-L1, PD-1. Just started chemo and what a great question. Hope we get answers. My biopsy says my cancer is kras g13c.

November 25, 2024
A MyLungCancerTeam Member

I don't think they collect data on that. If you die of lung cancer before, during or after chemo (or immunotherapy) it's just marked as lung cancer death.

November 25, 2024

Related Questions

View All
A MyLungCancerTeam Member asked a question 💭
Manteca, CA

A MyLungCancerTeam Member asked a question 💭
Cincinnati, OH

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In